Carbohydrate–insulin model
Carbohydrate–Insulin Model is a scientific theory that explains the relationship between the intake of carbohydrates and the production of insulin in the human body. This model is often used in the study of diabetes, obesity, and other metabolic disorders.
Overview[edit]
The Carbohydrate–Insulin Model (CIM) posits that the overconsumption of high-glycemic-load foods leads to an increased insulin secretion. This increased insulin secretion can lead to weight gain and, over time, to insulin resistance, a key factor in the development of type 2 diabetes.
Mechanism[edit]
The mechanism of the Carbohydrate–Insulin Model begins with the consumption of carbohydrates. When carbohydrates are consumed, they are broken down into glucose in the digestive system. This glucose then enters the bloodstream, causing blood sugar levels to rise. In response to this rise in blood sugar, the pancreas secretes insulin. Insulin is a hormone that allows cells to take in glucose and use it for energy.
If the body consistently takes in more glucose than it can use for energy, the excess glucose is stored as fat. Over time, this can lead to weight gain and obesity. Additionally, the constant demand for insulin can cause the pancreas to become overworked, leading to insulin resistance and potentially type 2 diabetes.
Criticism and Controversy[edit]
While the Carbohydrate–Insulin Model has been influential in the field of nutrition and metabolic health, it has also been the subject of criticism and controversy. Some researchers argue that the model oversimplifies the complex processes of metabolism and weight regulation. Others point out that many people consume high-carbohydrate diets without developing obesity or diabetes, suggesting that other factors, such as genetics and lifestyle, also play a significant role.
See Also[edit]
References[edit]

This article is a endocrinology stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
